The Eastern Analytical Symposium (EAS) Award for Outstanding Achievements will be presented to Peter de Boves Harrington on Tuesday, November 19.
The Eastern Analytical Symposium (EAS) Award for Outstanding Achievements was presented to Peter de Boves Harrington on Tuesday, November 19. Harrington gave a talk on “Chemometrics for the Masses: How to Painlessly Improve Your Science.”
Peter Harrington
Harrington received his PhD from the University of North Carolina-Chapel Hill in 1988. From 1987 to 1989 he created the DOS-based software platforms Resolve and Presager for identifying bacteria from their pyrolysis-mass spectra, while working for Kent Voorhees at the Colorado School of Mines. He joined the faculty of Ohio University (Athens, Ohio) in 1989. In 1992, he founded the Center for Intelligent Chemical Instrumentation. He has more than 200 publications, and has made more than 300 scientific presentations, including many plenary and keynote speeches around the world. In 2016, Harrington won the Ohio University College of Arts & Sciences Outstanding Faculty Research Award and the 2019 Eastern Analytical Symposium Award for Outstanding Achievement in Chemometrics. He is the Director of the Ohio University Center for Intelligent Chemical Instrumentation and is a Fellow of the American Academy of Forensic Sciences and the North American Academy of Sciences. Harrington’s current research focuses on the development and coupling of artificial intelligence to chemotyping by spectrometric measurements of botanical medicines and foods.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.